Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters
- PMID: 14630268
- DOI: 10.1016/s0360-3016(03)01373-7
Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters
Abstract
Purpose: To clarify the relationship between the percentage of lung receiving low radiation doses with concurrent chemotherapy and the occurrence of postoperative pulmonary complications in the treatment of esophageal carcinoma.
Methods: From 117 patients who underwent preoperative chemoradiation for esophageal cancer at our institution between 1998 and 2002, we selected 61 patients for whom complete pulmonary dose-volume histogram (DVH) data were available and analyzed the incidence of pneumonia and acute respiratory distress syndrome (ARDS) in this group. All patients received concurrent chemoradiation therapy, and 39 patients also received induction chemotherapy before concurrent chemoradiation. The median age was 62 years, and the median radiotherapy dose was 45 Gy. The percentage of lung volume receiving at least 10 Gy (V10), 15 Gy (V15), and 20 Gy (V20) were recorded from each pulmonary DVH.
Results: Eleven (18%) of the 61 patients had pulmonary complications, 2 of whom died after progression of pneumonia. Pulmonary complications were noted more often (35% vs. 8%, p = 0.014) when the pulmonary V10 was > or =40% vs. <40% and when the V15 was > or /=30% vs. < 30% (33% vs. 10%, p = 0.036). An apparent increase in pulmonary complication rate when V20 was > or =20% vs. <20% (32% vs. 10%, p = 0.079) was not significant. None of the other factors analyzed (surgical procedure, tumor location, use of induction chemotherapy, use of concurrent taxane-based chemoradiation, or smoking history) was associated with the occurrence of pulmonary complications. The median hospital stay was 17 days for patients who had pulmonary complications vs. 12 days for patients who did not (p = 0.08).
Conclusions: The use of multimodality therapy may require minimization of lung volume irradiation to levels lower than previously expected. Radiotherapy techniques that decrease the volume of lung receiving low radiation doses may significantly reduce the risk of this potentially life-threatening complication.
Similar articles
-
Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):692-9. doi: 10.1016/j.ijrobp.2005.08.002. Epub 2005 Oct 19. Int J Radiat Oncol Biol Phys. 2006. PMID: 16242257
-
Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):754-61. doi: 10.1016/j.ijrobp.2006.06.002. Epub 2006 Sep 11. Int J Radiat Oncol Biol Phys. 2006. PMID: 16965865
-
Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1484-93. doi: 10.1016/j.ijrobp.2004.05.056. Int J Radiat Oncol Biol Phys. 2004. PMID: 15590179
-
Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma.Ann Thorac Surg. 1990 Mar;49(3):348-54; discussion 354-5. doi: 10.1016/0003-4975(90)90237-z. Ann Thorac Surg. 1990. PMID: 2106845 Review.
-
Induction therapy does not increase surgical morbidity after esophagectomy for cancer.Ann Thorac Surg. 2004 Nov;78(5):1783-9. doi: 10.1016/j.athoracsur.2004.04.081. Ann Thorac Surg. 2004. PMID: 15511475 Review.
Cited by
-
Principles of modern radiation techniques for esophageal and gastroesophageal junction cancers.Gastrointest Cancer Res. 2009 Mar;3(2 Suppl):S6-S10. Gastrointest Cancer Res. 2009. PMID: 19461922 Free PMC article.
-
Self-expanding stent effects on radiation dosimetry in esophageal cancer.J Appl Clin Med Phys. 2013 Jul 8;14(4):4218. doi: 10.1120/jacmp.v14i4.4218. J Appl Clin Med Phys. 2013. PMID: 23835387 Free PMC article.
-
Is dose escalation achievable for esophageal carcinoma?Rep Pract Oncol Radiother. 2015 Jan 5;20(2):135-40. doi: 10.1016/j.rpor.2014.12.006. eCollection 2015 Mar-Apr. Rep Pract Oncol Radiother. 2015. PMID: 25859404 Free PMC article.
-
Risk factors for pulmonary complications after esophagectomy for esophageal cancer.Surg Today. 2014 Mar;44(3):526-32. doi: 10.1007/s00595-013-0577-6. Epub 2013 Apr 14. Surg Today. 2014. PMID: 23584275
-
Multimodality treatment of esophageal cancer: a review of the current status and future directions.Curr Oncol Rep. 2006 May;8(3):174-82. doi: 10.1007/s11912-006-0017-5. Curr Oncol Rep. 2006. PMID: 16618381 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical